Coronavirus (COVID-19)—MHRA announces vaccines for variants to be fast-tracked

Coronavirus (COVID-19)—MHRA announces vaccines for variants to be fast-tracked

The Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance, developed through the ACCESS Consortium—an international coalition of regulatory authorities—on strain changes in coronavirus vaccines which have already been authorised. The guidance states that vaccines which are modified to respond to new strains of coronavirus (COVID-19) will not require full clinical studies, as they are not an entirely novel product. Instead, the guidance states that the relevant authorities may take a regulatory approach such as that for seasonal updates for influenza vaccines.

Announcing the publication of the ACCESS Consortium guidance, MHRA Chief Scientific Officer, Dr Christian Schneider, said: ’The announcement today also demonstrates the strength of our international partnerships with other regulators and how our global work can help ensure faster access to life-saving vaccines in the UK and around the world.’

He continued by reassuring the public that that safety, quality, or the effectiveness of the vaccines will not be comprised.

For further information, read the guidance here.

Source: Modified COVID-19 vaccines for variants to be fast-tracked, says MHRA and other regulators

Related Articles:
Latest Articles: